PRE TAX NTA |$3.47

Value as at close of business on 15 November 2024

Prof Misty Jenkins AO | Sohn Hearts & Minds Conference

At this year's Sohn Hearts & Minds Conference, we heard from Prof Misty Jenkins. Misty is a NHMRC fellow and laboratory head of the Immunology Division at the Walter and Eliza Hall Institute. Misty leads the immunotherapy program within the Brain Cancer Centre and is dedicated to discovering novel immunotherapy targets for high grade gliomas in adults and children. Her research focusses on the development of novel chimeric antigen receptor T cells for brain cancer. Her group also uses cutting edge two-photon microscopy combined with mouse models of brain cancer to investigate the tumour microenvironment and uncover unique biology of brain tumours.

Misty has a PhD in Immunology from The University of Melbourne, followed by postdoctoral positions at The Universities of Oxford, Cambridge and the Peter MacCallum Cancer Centre.  

Prof Jenkins was awarded the L’Oreal for Women in Science Fellowship (2013), was Tall Poppy of the year (2015), was awarded the Top100 Women of Influence award (2016) and was inducted onto the Victorian Honour Roll of Women in 2020.

You can watch her presentation below.


This communication has been prepared by Hearts and Minds Investments Limited (ABN 61 628 753 220). In preparing this publication the investment objectives, financial situation or particular needs of an individual have not been considered. You should not rely on the opinions, advice, recommendations and other information contained in this publication alone. The inclusion of third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the third-party content. This publication has been prepared to provide you with general information only. It is not intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Past performance is not a reliable indicator of future performance.

Recent Posts

Read the latest insights
A curated list of HM1 investor updates, portfolio news and other interesting articles.
Read More
...